+44-330-822-4832
+44-330-822-4832Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal of Pain & Relief received 1131 citations as per Google Scholar report
Dr. Jan M. Keppel Hesselink, MD, PhD is professor of molecular pharmacology at the university of Witten/Herdecke (Germany). He was elected as Fellow of the Pharmaceutical Faculty in Medicine (FFPM) in the UK. He worked several years at Bayer AG in Germany as VP CNS and business head CNS. He was advisor R&D and business strategies to the Dutch Royal Acadamy of Science (KNAW). Currently he is a consultant for life science companies and investors, founder of the Chonic Pain Coalition and of the Institute for Neuropathic Pain. His current focus is topical analgesic cream development and endocannabinoids as analgesics.
Dr. Jan M. Keppel Hesselink current focus is topical analgesic cream development and endocannabinoids as analgesics.
| Jan M Keppel Hesselink and David J Kopsky |
| Review Article: J Pain Relief 2017, 7:313 |
| DOI: 10.4172/2167-0846.1000313 |
| Jan MK Hesselink and David J Kopsky |
| Case Report: J Pain Relief 2016, 6:284 |
| DOI: 10.4172/2167-0846.1000284 |
| Jan M Keppel Hesselink |
| Editorial: Clin Res Foot Ankle 2014, 3: e105 |
| DOI: 10.4172/2329-910X.1000e105 |
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 
